Oslo, Norway, 19 February 2020
Vistin Pharma ASA will release its fourth quarter 2019 results on
Friday 28 February 2020.
Vistin Pharma will host a conference call for all shareholders and interested
parties on 28 February at 08:30 CET. There will be a Q&A session following the
management discussion.
The conference call will be held in Norwegian.
The fourth quarter conference call will be available via web and audio through
the following access points:
Telephone conference:
Confirmation Code:........ 6394327
International Dial-In:........ +44 (0) 2071 928000
Norway, Oslo:................ +47 23960264
United States, New York: +16315107495
Webcast:
https://edge.media-server.com/mmc/p/zxt9i6wn
*****
For further information, please contact:
Hans Lysheim
Interim CFO
+47 93404313
Hans.Lysheim@vistin.com (mailto:Hans.Lysheim@vistin.com)
About Vistin Pharma | www.vistin.com
Vistin Pharma is a Norwegian pharmaceutical company producing Metformin
Hydrochloride (API). The Metformin is also available as Direct Compressible
lubricated granules. As a solely dedicated European Metformin producer, Vistin
Pharma is a well-positioned supplier to leading pharmaceutical companies. Vistin
Pharma is headquartered in Oslo, Norway, and has highly qualified employees and
a dedicated manufacturing facility in Kragerø.